SCHEMBL21566445

SCHEMBL21566445

c1ccc(-c2cccc(-n3c4ccccc4c4ccc5c6ccccc6n(-c6ccc7ccccc7c6)c5c43)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HSP90AA1 P07900 2/20 0.36
HTT P42858 2/20 0.36
FAAH O00519 1/20 0.36
PKM P14618 1/20 0.36
MGLL Q99685 1/20 0.36
PDE10A Q9Y233 1/20 0.35
MAPK10 P53779 2/20 0.35
MAPK9 P45984 1/20 0.35
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23233610 0.99 ATM (0.41) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL23233614 0.99 ATM (0.41) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL24356702 0.95 L3MBTL1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL19769427 0.95 L3MBTL1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL23232312 0.95 L3MBTL1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL24356545 0.95 L3MBTL1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL24356678 0.94 HSD17B1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL25775278 0.94 HSD17B1 (0.44) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL23233611 0.93 KDM4E (0.41) ATML3MBTL1KDM4EHSD17B1HSD17B2
SCHEMBL19653674 0.93 L3MBTL1 (0.43) ATML3MBTL1KDM4EHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200227-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-06-22 US disclosed
US-20230200227-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-06-22 US disclosed
US-20230136708-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20230136708-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2023-05-04 US disclosed
WO-2022146012-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE 삼성에스디아이 주식회사 2022-07-07 WO disclosed
WO-2022086296-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2022-04-28 WO disclosed
US-20210111350-A1 PHOSPHORESCENT HOST COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-04-15 US disclosed
US-20190348612-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190348612-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OCIAD2, OR10J3, OCIAD1 ATM 4007/4885L3MBTL1 4726/4885KDM4E 3780/4885
US-20210111350-A1 PHOSPHORESCENT HOST COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE ORC3, CRY1, OSTC ATM 4137/4885L3MBTL1 4140/4885KDM4E 4468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.